PMPolina A. Makarova

Polina A. Makarova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Polina A. Makarova has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transformation of the oral microbial community under the influence of materials used in prosthetic dentistry

    by P. A. Makarova, D. S. Gonchikova, E. V. Mokrenko, A. Yu. Borisenko, A. M. Rogozhnikova, S. S. Salikhov, О. N. Nikitin, A. A. Kravtsov, П. А. Макарова, Д. С. Гончикова, et al.

    Background. The oral microbial ecosystem is highly sensitive to external influences, including the insertion of orthopedic restorations. The composition of the prosthesis material, its microrelief, and chemical characteristics can alter the conditions for the proliferation and interaction of microorganisms, which in some cases leads to an imbalance in the normal flora. The aim of this study was to comprehensively assess the dynamics of the oral microflora in individuals with orthopedic restorations and to establish a correlation between the denture material and changes in the taxonomic composition of microorganisms. Materials and methods. Three groups of patients were examined: those with sanitized oral cavity without dentures and signs of periodontal disease, those with fixed metal-ceramic restorations, and those with removable acrylic dentures. In the bacteriology laboratory of Irkutsk State Medical University, cultures were performed on appropriate nutrient media to obtain microorganism growth and subsequent species identification based on morphological, tinctorial, cultural, biochemical, and antigenic characteristics. Results. A gradient increase in total microbial counts was observed: 1.48×10 7 CFU/ml (88% of normal) in the control group, 4.18×10 7 CFU/ml (64% with dysbiosis) in the fixed denture group, and 8.45×10 7 CFU/ml (82% with severe dysbiosis) in the removable denture group. In the removable denture group, C. albicans (94%, 2.38×10 6 CFU/ml), S. epidermidis, and anaerobes predominated, correlating with a high risk of stomatitis. A significant correlation was found between the duration of denture use and increased counts (r = 0.78), as well as an inverse relationship between hygiene quality and biofilm thickness ( r= -0.65). Acrylic dentures were found to cause the most severe dysbiosis, with a risk of stomatitis and bacteremia. Conclusions. The authors’ comprehensive microbiological analysis data demonstrate that the presence of orthopedic structures in the oral cavity is a significant factor disrupting the stability of the microbial community. It was established that the nature of changes in the microbiome is directly related to the chemical composition and physical properties of the prosthesis material: a significant correlation was found between the two.

  • Open Access

    Development of oxygen-producing antihypoxants, oxygen fuzes and oxygen generators in Russia

    by Natalya A. Urakova, Уракова Наталья Александровна, Aleksandr L. Urakov, Ураков Александр Ливиевич, Petr D. Shabanov, Шабанов Петр Дмитриевич, Oleg N. Ergashev, Eugenii V. Mokrenko, Polina A. Makarova

    It is reported that pharmacologists in St. Petersburg and Izhevsk have discovered several new groups of medicines. Oxygen-producing antihypoxants, oxygen fuzes, and oxygen generator, invented on the initiative of Alexander Urakov, are listed in chronological order. It is shown that new drugs were created by physico-chemical repurposing of hydrogen peroxide from acidic antiseptics to warm alkaline hydrogen peroxide solution. The list of invented medicines, the composition of the ingredients of the created medicines and the mechanism of their action when applied topically are given. It is reported that the pharmacological target of oxygen-producing antihypoxants and oxygen fuze is the enzyme catalase, which is present in all tissues of the human body. It is indicated that catalase breaks down hydrogen peroxide into water and molecular oxygen at a tremendous rate. A chemical calculation is given showing that at a temperature of +42°C, 1 liter of oxygen gas is formed from 100 ml of a 3% solution of hydrogen peroxide under the action of catalase. It is shown that the involvement of Professor Peter Shabanov in the study accelerated and expanded the development of oxygen-producing antihypoxants and led to the discovery of intrapulmonary, endobronchial and endotracheal injections, as well as a new group of drugs—oxygen generators. This information proves that Russia became the first country in the world to invent warm alkaline hydrogen peroxide solutions for inhalation, intrapulmonary, endotracheal and endobronchial injections for the purpose of emergency oxygenation of blood through the lungs in respiratory obstruction and asphyxia. In addition, Russia is also the birthplace of “oxygen fuzes” and the first individual portable oxygen generator for first aid in case of suffocation caused by lack of oxygen in the inhaled air.


  • New technology for manufacturing a hollow prosthesis-obturator for replacement prosthetics of postresection defects of the upper jaw

    by E.V Mokrenko, V.G. Galonskiy, I.G. Aleshkin, V.V. Gazinsky, Y.M. Podkorytov, P.A. Makarova

    Given the persistently high incidence of facial trauma in people of all ages, there is a shortage of new prosthetic treatments for patients with such defects. The aim of this study was to improve the technology for manufacturing a hollow maxillary obturator prosthesis to increase the effectiveness of rehabilitation for patients with maxillary post-resection defects. Based on an analysis of similar obturator manufacturing methods, a new method for fabricating a thin-walled hollow maxillary obturator prosthesis was developed. The model developed by the authors exhibits increased congruence with the prosthetic bed and strength while maintaining the thinness of the structure. The model of the prosthesis created by the authors has an increased accuracy of the prosthesis compliance with the prosthetic bed and increased strength properties of the prosthesis while maintaining the thinness of the structure. During clinical trials of this model, researchers observed complete restoration of speech, swallowing and chewing functions in patients with the elimination of oroantral and / or oronasal communication, as well as aesthetic restoration of the appearance of the facial skeleton when replacing missing anatomical structures with prosthetic structures. In the invention developed by the authors, there is no suture connection of the obturator with the prosthesis base, accordingly, there is no decrease in strength properties, the prosthesis more accurately matches the prosthetic bed, good tightness is observed, speech phonation in patients is preserved and there is no nasal tone.

  • Open Access

    Pharmacologic management of pain in intraoperative and postoperative periods in pediatric practice

    by Ekaterina E. Yakovleva, Eugenii R. Bychkov, Anna N. Galustyan, Natalia A. Kuritsina, Eugenii V. Mokrenko, Polina A. Makarova, Petr D. Shabanov

    Pain management, along with the prevention of infectious complications, is among the primary objectives of the perioperative period. In infants and newborns, intense pain triggers a stress response. In similar surgical interventions, the stress response activated by afferent neuronal impulses from the site of injury in newborns is greater in magnitude but shorter compared with that in adults. Effective analgesia with opioids during cardiac surgery has been shown to improve surgical outcomes. Prolonged, high-intensity pain in a newborn with ineffective analgesia leads to the progression of such pathological conditions as hypoxia, metabolic acidosis, impaired liver and kidney function, an increased risk of sepsis, disseminated intravascular coagulation, and higher neonatal mortality. At present, the capabilities of traditional analgesia methods remain limited. In this regard, the main approaches to improving the efficacy of pain management in pediatric practice include various regimens combining non-opioid analgesics, supplemented with opioids if necessary, as well as the development of new effective and safe pharmacologic agents with analgesic activity.